Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

Following Passage of First U.S. Law of its Kind, California Medical Professionals Now Face Loss of License for COVID-19 Speech

By Fay L. Szakal on October 7, 2022
Email this postTweet this postLike this postShare this post on LinkedIn

California Governor Gavin Newsom has signed into law a controversial bill, AB 2098, giving the Medical Board of California and the Osteopathic Medical Board of California the authority to investigate, challenge and rescind the licenses of California physicians and surgeons who engage in “unprofessional conduct” with regard to disseminating “misinformation or disinformation” related to COVID-19.

The bill stems from a House resolution of the California State Assembly which declared “health misinformation” to be a “public health crisis” and noted that “[m]ajor news outlets have reported that some of the most dangerous propagators of inaccurate information regarding the COVID-19 vaccines are licensed health care professionals.”

AB 2098 amends California’s Business and Professions Code to include in the preexisting definition of unprofessional conduct the “disseminat[ion] of misinformation or disinformation related to COVID-19, including false or misleading information regarding the nature and risks of the virus; its prevention and treatment; and the development, safety and effectiveness or COVID-19 vaccines.” Notably, disinformation is defined as misinformation that is deliberately disseminated with “malicious intent” or an “intent to mislead,” while misinformation is defined as false information that is “contradicted by contemporary scientific consensus contrary to the standard of care.”

The latter definition has raised the most controversy, as organizations representing physicians and surgeons have pointed out that “contemporary scientific consensus” is often subject to debate and change. Dissenting groups have noted that scientific guidance with regard to COVID-19 treatment, prevention, and vaccination changed multiple times over the past two years and have queried whether doctors providing the current “consensus” would be liable for misinformation once the consensus changes yet again. The drafters of the law have stated that this is not the practical intention, but concern still lingers as the implementation of the definition of “misinformation” has yet to be vetted.

Other dissenters have claimed that any restriction on physician speech regarding COVID-19 is solely politically based and a violation of the medical professionals’ right to free speech. Proponents of the law, however, have noted that medical advice of any kind is professional speech that should be monitored and regulated by the appropriate medical boards for the health and safety of society.

Despite the scrutiny it faced, AB 2098 is now the first law of its kind in the United States and is likely to raise further controversy when it is initially invoked by the medical boards. It remains to be seen whether other states will pursue statutory measures to protect citizens from COVID-19 “misinformation and disinformation” as the virus continues to be ever-present and resistance to vaccinations and boosters becomes more common.

Photo of Fay L. Szakal Fay L. Szakal

Partner, Corporate, Healthcare and Real Estate

Fay is a results-driven corporate and business lawyer who provides general and specialized representation to small, midsized and large business entities, including for-profit and nonprofit businesses, in corporate, real estate, and healthcare transactions.

She represents clients in

…

Partner, Corporate, Healthcare and Real Estate

Fay is a results-driven corporate and business lawyer who provides general and specialized representation to small, midsized and large business entities, including for-profit and nonprofit businesses, in corporate, real estate, and healthcare transactions.

She represents clients in M&A, the formation of business entities, the transfer or sale of membership interest or ownership equity, statutory mergers, private equity deals, financing transactions, joint ventures, and other commercial transactions. Her work encompasses the drafting and negotiation of an inclusive range of corporate agreements and contracts. She also drafts and negotiates employment and consultant agreements, including within the context of acquired businesses for which the seller plays a continuing role as a consultant or employee, as well as restrictive covenants, such as non-competes and non-solicitation agreements.

Fay supports the firm’s healthcare sector clients by assisting with the formation and structuring of new healthcare entities, and with navigating New Jersey’s corporate practice of medicine doctrine. She plays a significant role in identifying potential regulatory red flags in transactions, including issues arising under the Stark Law and federal and state anti-kickback statutes.

For clients in the commercial real estate industry, Fay serves as a strategic advisor on entity formation, corporate due diligence, financing options, and the contractual allocation of risk. She is a resource for clients who wish to pursue tax incentives as a financing tool for commercial, mixed-use, and residential projects that demonstrate a financing gap. Her knowledge of the complexities of tax credits as a business development incentive extends to her work with clients interested in utilizing the New Jersey Film and Digital Media Tax Credit Program, a significant incentive designed to attract film, television, and digital media production to the state.

Fay provides comprehensive services to nonprofit entities, including 501(c)(3), (c)(4), and (c)(6) organizations such as public charities, foundations, and membership associations, to ensure that a non-profit business entity’s mission can be effectively pursued within the parameters of any applicable tax exemption. Her work for the non-profit sector encompasses entity formation and tax-exempt applications, governance and strategy guidance, operational support and general counsel services, and counseling on compliance and risk management including adherence to the New Jersey Nonprofit Corporations Act.

Results may vary depending on your particular facts and legal circumstances.

Contact information:

fszakal@greenbaumlaw.com | 732.476.3204 | vCard

For more information visit the Greenbaum, Rowe, Smith & Davis LLP website.

Email
Show more Show less
  • Posted in:
    Health Care and Life Sciences
  • Blog:
    Healthcare Perspectives
  • Organization:
    Greenbaum, Rowe, Smith & Davis LLP
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo